

Improving Healthcare for Women & Generating Real Investor ROI
Virtual Event
In 2024, women’s health medtech company Gynesonics reached a successful exit to Hologic, a company later acquired by Blackstone in one of the largest transactions in the sector.
What’s less visible is the journey behind that outcome. This session examines the capital and execution realities behind building a company in this category including the moments where the investment case is tested, challenged, and, in many cases, fails.
This discussion will unpack:
how companies become fundable
what drives investor conviction over time
and why many opportunities don’t make it through the full journey.
Designed for:
Angel investors and family offices
Healthcare and medtech investors
Capital allocators evaluating women’s health
Attendance is intentionally curated to ensure a high-quality discussion.
Speakers:
Nelson Whistance, President and CEO, Channel Medsystems
Tara Murphy, Vice President, Channel Medsystems
Alexander Schmitz, Partner, Endeavour Vision
Attendance is by approval. Places are limited.